Impact of anti-tuberculosis drug use on treatment outcomes in patients with pulmonary fluoroquinolone-resistant multidrug-resistant tuberculosis: A nationwide retrospective cohort study with propensity score matching

CONCLUSION: A therapeutic regimen guided by drug-susceptibility testing can improve the treatment of patients with pulmonary FQr-MDR-TB. In addition to core anti-TB drugs such as BDQ and LZD, treatment of susceptible strains with later-generation FQs and KM may be beneficial in FQr-MDR-TB patients with limited treatment options.PMID:37254489 | DOI:10.4046/trd.2023.0040

Source: Respiratory Care - May 31, 2023 Category: Respiratory Medicine Authors: Hongjo Choi Dawoon Jeong Young Ae Kang Doosoo Jeon Hee-Yeon Kang Hee Jin Kim Hee-Sun Kim Jeongha Mok Source Type: research